Trump's claims questioned; Two Iran pain trades; $3500 body scan craze
Want to get this in your inbox at lunchtime every weekday? Financial Review subscribers can sign up for The Brief newsletter here. Plus start your day with our Before the Bell newsletter and read a full wrap of the day's news in Market Wrap.
In today's news, satellite images question Donald Trump's claim that Iran's atomic sites are destroyed, there are two surprising 'pain' trades from Iran, and rich Aussies are paying $3500 for body scans.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

AU Financial Review
11 hours ago
- AU Financial Review
Trump's claims questioned; Two Iran pain trades; $3500 body scan craze
Want to get this in your inbox at lunchtime every weekday? Financial Review subscribers can sign up for The Brief newsletter here. Plus start your day with our Before the Bell newsletter and read a full wrap of the day's news in Market Wrap. In today's news, satellite images question Donald Trump's claim that Iran's atomic sites are destroyed, there are two surprising 'pain' trades from Iran, and rich Aussies are paying $3500 for body scans.


Perth Now
3 days ago
- Perth Now
Banks, miners drag ASX lower
Gains in the healthcare sector were offset by falls in the big four banks and major miners, with the local market falling for its fourth consecutive trading day on Friday. The ASX 200 dropped 18.20 points or 0.21 per cent to 8,505.50 on a quiet day of trading. The broader All Ordinaries slipped 17.90 points or 0.20 per cent to 8,723.50. Australia's dollar traded down against the US dollar and is now buying 64.83 US cents. Five of the 11 sectors rose but falls in banks and mining shares dragged the market lower. NewsWire / Jeremy Piper Credit: News Corp Australia On a mixed day for investors, strong gains out of the utilities and healthcare sectors were offset by falls from the big banks and miners. CSL shares jumped 0.63 per cent to $240.21, Pro Medicus gained 1 per cent to $276.81 and ResMed added 1.40 per cent to $39.16 on a strong day for the healthcare sector. Commonwealth Bank fell from a record high close on Thursday, down 0.2 per cent to $182.53. National Australia Bank slipped 0.5 per cent to $38.91, while Westpac came off 1.1 per cent to $33.21 and ANZ dropped to 2.5 per cent to $28.39. It was a mixed day for the big miners, with BHP eking out a small gain up 0.22 per cent to $36.21, while Rio Tinto fell 1.33 per cent to $102.17 and Fortescue dropped 0.54 per cent to $14.69. Overall five of the 11 sectors closed higher despite the market falling. On a reversal of trade in recent days, the price of oil and gold fell after the White House said US President Donald Trump would decide on strikes on Iran 'within the next two weeks' alleviating fears of an immediate escalation in the Middle East crisis. The price of crude oil futures fell 2.9 per cent to $US76.50 a barrel on the news, while gold futures also dropped 1.4 per cent to $US3,362 an ounce. Healthcare shares are on the rise on an overall weak day of trading: NewsWire / Christian Gilles Credit: News Corp Australia AMP head of investment strategy and chief economist Shane Oliver said stocks remained at 'high risk' of a pullback as markets grappled with multiple economic concerns. 'Global and Australian shares have seen a strong rebound from their April lows – but they remain at high risk of a sharp near term pull back as the risk of an oil supply disruption flowing from the war with Iran is high and Trump's tariff threat is far from resolved,' he said. 'On the tariff front it is notable that the 9th July tariff deadline is rapidly approaching and no deals have been struck beyond that with the UK, with indications that some countries may end up with tariffs well above 10 per cent.' In company news, Pointsbet Holdings announced a temporary pause in trading. It comes as rival sports wagering company Betr announced a renewed takeover bid in what it is calling a superior proposal for Pointsbet compared to Japanese gaming giant Mixi. Web Travel shares are in the red down 0.44 per cent to $4.50 after announcing former Virgin Australia chief executive Paul Scurrah and JB Hi Fi director Melanie Wilson would be joining the board as independent non-executive directors.


7NEWS
3 days ago
- 7NEWS
Shoppers are racing to buy Aussie collagen brand Calmerceuticals that sells one every minute
There's a collagen craze happening across Australia right now and it's not just another influencer trend. One homegrown brand is causing a serious stir in the beauty world, selling one product every minute and struggling to keep up with demand. Meet Calmerceuticals, the inner-beauty brand that's winning over Aussies, scientists and skincare lovers alike. Behind it is Rose Rayner, a beauty entrepreneur who spent more than seven years in deep research mode, building a collagen formula from the ground up. After trying countless supplements with big promises and little science, Rose took matters into her own hands and the result is what the brand calls one of the most scientifically backed formulas on the market. Her hero product, the VERISOL® Enhanced Marine Collagen, is already a cult favourite, thanks to its visible results and high dose of bioavailable ingredients. Each $95 box contains 14 ready-to-drink sachets (with 10,000 mg of collagen peptides per serve), and customers say it's helped improve everything from skin firmness to nail strength and glow. The secret is a unique blend of VERISOL® F collagen peptides (proven to reduce wrinkle depth by up to 70 per cent), Cultavit® B-complex for healthy hair and nails, plus skin-loving actives like hyaluronic acid, vitamin C and polyphenol antioxidants. The brand says the formula is designed to survive digestion and actually reach your bloodstream, which is a major difference from other powders and collagen pills that often go to waste. It comes in two fruity flavours, Wild Berry or Mango & Mandarin and you can buy either 14 or 28 sachets at a time, depending on how committed you are. For those after a more instant skin fix, the brand's Deep Hydrating Collagen Facemask is also a major hit. At $69 for a pack of five, it's a luxe hydrogel treatment that visibly plumps, hydrates and brightens your face in just 20 minutes. The biodegradable formula is gentle yet powerful, blending hydrolysed collagen with niacinamide, hyaluronic acid and botanical extracts. It helps even out skin tone, reduce pigmentation, smooth texture, and calm any redness. Perfect before an event or as a Sunday night ritual, the mask has become a go-to for many who want their skin to look dewy, fresh and firm without piling on makeup. What sets Calmerceuticals apart is its clinical credibility. Rose worked with Australian scientists for nearly a decade to test and refine her formula, benchmarking it against market leaders and proving its results through independent trials. In fact, her work has even landed her in Forbes, and the brand has caught the eye of US investors as it plans a global expansion into salons, Amazon Australia and more. Demand is skyrocketing, especially as winter dries out our skin and we all look for more effective ways to glow. Whether you're a beauty minimalist or a skincare obsessive, Calmerceuticals is shaping up to be one of the most trusted (and best-selling) names in collagen right now.